# Innate Pharma SA: Form 6-K, filed Feb 18, 2026

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2026-02-18
- Accepted by EDGAR: Feb 18, 2026, 06:17 ET
- Period: 2026-02-18
- Accession: 0001628280-26-008778
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000162828026008778/a6k-iphx260218.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000162828026008778/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000162828026008778/a6k-iphx260218.htm

Filed Feb 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-008778. Last ingested by Listed: Oct 27, 2026, 07:14 ET. No prices; not investment advice.